AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Leerink Partners Raises PT on Intuitive Surgical, Maintains Buy Rating
ByAinvest
Thursday, Aug 7, 2025 12:44 pm ET1min read
Leerink Partners raised their price target for Intuitive Surgical (ISRG) to $593, maintaining a Buy rating. The company reported strong Q2 2025 results, with revenue and EPS exceeding expectations. Robust growth in all segments and increased da Vinci system placements in the US drove the results. The firm also raised its full-year guidance for procedure growth and gross margin.
Leerink Partners has raised its price target for Intuitive Surgical (ISRG) to $593, maintaining a Buy rating following the company's robust Q2 2025 results. The report highlights strong revenue and EPS growth, driven by robust demand for Intuitive's da Vinci robotic surgical systems.Intuitive Surgical reported revenue of $2.44 billion for the quarter, up 21% year-over-year, with a 17% increase in procedure volumes and record placements of 395 da Vinci systems globally. The da Vinci 5 systems, which received EU certification for adult and pediatric procedures, were particularly notable, with 180 systems placed, up from 70 a year earlier. The total installed base expanded to 10,488 systems, a 14% increase [2].
The company also updated its 2025 gross margin outlook to 66%, adjusting for tariff effects, and reaffirmed expectations for 15–17% global procedure growth this year, reflecting strong demand as hospitals address surgical backlogs and broaden access to robotic procedures [2].
Leerink Partners' analysts noted that the company's growth is driven by its leadership in robotic-assisted, minimally invasive surgery, and the increasing adoption of its da Vinci systems. The firm also raised its full-year guidance for procedure growth and gross margin, reflecting the company's continued innovation and market leadership.
Intuitive Surgical's strong performance in Q2 2025 underscores its position as a global technology leader in robotic-assisted, minimally invasive surgery. The company's focus on innovation, such as the da Vinci 5 systems, and its ability to adapt to changing market conditions have positioned it well for future growth.
References:
[1] https://isrg.intuitive.com/
[2] https://finance.yahoo.com/news/intuitive-surgical-inc-isrg-installs-151004972.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet